# Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

> **NCT02964455** · PHASE1 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 12 (actual)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Nedaplatin
- **RADIATION:** chest radiation

## Key facts

- **NCT ID:** NCT02964455
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-12
- **Final completion:** 2020-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964455, "Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02964455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*